Lepore, Domenico
 Distribuzione geografica
Continente #
NA - Nord America 1.436
EU - Europa 1.316
AS - Asia 1.016
SA - Sud America 259
AF - Africa 20
OC - Oceania 1
Totale 4.048
Nazione #
US - Stati Uniti d'America 1.395
DE - Germania 502
SG - Singapore 466
CN - Cina 263
BR - Brasile 214
SE - Svezia 199
IT - Italia 119
FR - Francia 101
UA - Ucraina 92
GB - Regno Unito 77
VN - Vietnam 59
FI - Finlandia 55
IN - India 50
IE - Irlanda 48
ID - Indonesia 37
HK - Hong Kong 25
RU - Federazione Russa 25
AR - Argentina 22
BD - Bangladesh 18
BE - Belgio 18
PL - Polonia 18
JP - Giappone 17
MX - Messico 17
CA - Canada 15
TR - Turchia 15
IQ - Iraq 13
ES - Italia 12
IR - Iran 12
KR - Corea 10
NL - Olanda 9
ZA - Sudafrica 9
AT - Austria 7
CO - Colombia 7
CZ - Repubblica Ceca 7
PH - Filippine 7
TW - Taiwan 6
PT - Portogallo 5
CL - Cile 4
EC - Ecuador 4
GR - Grecia 4
LT - Lituania 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
BY - Bielorussia 3
CH - Svizzera 3
JM - Giamaica 3
PY - Paraguay 3
TN - Tunisia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
KE - Kenya 2
KG - Kirghizistan 2
MA - Marocco 2
NO - Norvegia 2
NP - Nepal 2
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
HN - Honduras 1
KW - Kuwait 1
LU - Lussemburgo 1
NI - Nicaragua 1
PA - Panama 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 4.048
Città #
Chandler 267
Singapore 192
Ashburn 119
Los Angeles 68
Ann Arbor 56
Jacksonville 55
Beijing 54
New York 52
San Mateo 49
Dublin 45
Hefei 40
Marseille 39
Milan 31
Jakarta 30
Munich 29
Nanjing 29
Helsinki 28
Boston 27
Hong Kong 24
Dallas 23
Wilmington 22
Nanchang 21
Princeton 20
Woodbridge 20
Dearborn 19
Cattolica 18
Ho Chi Minh City 18
Rome 18
Brussels 17
Houston 17
Nürnberg 17
São Paulo 16
The Dalles 16
Moscow 15
Tokyo 15
Hanoi 14
Redmond 14
Augusta 13
Seattle 13
Fairfield 12
Dhaka 11
Pune 11
Frankfurt am Main 10
Kent 10
Seoul 10
Warsaw 10
Lancaster 9
Lawrence 9
Andover 8
Atlanta 8
Brooklyn 8
Izmir 8
Buffalo 7
Denver 7
Düsseldorf 7
London 7
Mexico City 7
Santa Clara 7
Bremen 6
Detroit 6
Hebei 6
Leawood 6
Manchester 6
Montreal 6
Orem 6
Poplar 6
Redwood City 6
Taichung 6
Turku 6
Boardman 5
Brno 5
Chennai 5
Hangzhou 5
Kish 5
Lappeenranta 5
Shenyang 5
University Park 5
Amsterdam 4
Bogotá 4
Busto Arsizio 4
Fremont 4
Kunming 4
Madrid 4
Paris 4
Pescara 4
Rio de Janeiro 4
Roubaix 4
San Francisco 4
Tashkent 4
Tianjin 4
Vienna 4
Wroclaw 4
Baghdad 3
Belo Horizonte 3
Bexley 3
Changchun 3
Changsha 3
Da Nang 3
Fuzhou 3
Isidro Casanova 3
Totale 1.936
Nome #
Cortical visual function in preterm infants in the first year. 262
Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings 205
Visual function at 35 and 40 weeks' postmenstrual age in low-risk preterm infants. 200
Effectiveness of Ketorolac Tromethamine in Prevention of Severe Retinopathy of Prematurity. 188
Occipital porencephaly in a child with gyrate atrophy of the choroid and retina. 179
Analysis of risk factors for progression to treatment-requiring ROP in a single neonatal intensive care unit: is the exposure time relevant? 179
An epidemiological analysis of retinopathy of prematurity over 10 years. 148
Chronic taaurine supplementation ameliorates oxidative stress and Na+ K+ ATPase impairment in the retina of diabetic rats 144
Early visual and neuro-development in preterm infants with and without retinopathy 137
Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings 136
Phenylephrine eye drops in pediatric patients undergoing ophthalmic surgery: incidence, presentation, and management of complications during general anesthesia 132
A cost effectiveness analysis of cataract surgery 122
Atlas of fluorescein angiographic findings in eyes undergoing laser for retinopathy of prematurity 120
Phenylephrine eye drops in pediatric patients undergoing ophthalmic surgery: Incidence, presentation, and management of complications during general anesthesia 117
Analysis of risk factors for progression to treatment-requiring ROP in a single neonatal intensive care unit: is the exposure time relevant? 113
Why Should We Monitor (1-3)- -D-Glucan Levels during Invasive Candidiasis? Just Ask Your Ophthalmologist! 113
Transfusion-Free Survival Predicts Severe Retinopathy in Preterm Neonates. 98
Functional and morphologic findings at four years after intravitreal bevacizumab or laser for type 1 ROP 97
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 95
Convolutional neural network based on fluorescein angiography images for retinopathy of prematurity management 91
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 89
The role of retinal imaging in the management of abusive head trauma cases 86
Taser-Related Ocular Injuries: A Review of the Literature and Medico-Legal Implications 85
Retinopathy of Prematurity Reactivated 28 Months after Injection of Ranibizumab 77
Effect of topical antiinflammatory drugs on mechanical behavior of rabbit cornea 68
Bilateral fixed mydriasis reversible during orthopedic surgery in the prone position 67
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial 61
Cord blood transfusions in extremely low gestational age neonates to reduce severe retinopathy of prematurity: results of a prespecified interim analysis of the randomized BORN trial 60
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE next 55
Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226) REPLY 55
Re: Yu et al.: Releasable encircling band for primary rhegmatogenous retinal detachment (Ophthalmology 2014;121:2504-5) 55
Re: Lepore et al.: Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings (Ophthalmology 2014;121:2212-9) Reply 50
2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial 48
Early angiographic signs of retinopathy of prematurity requiring treatment 47
International Classification of Retinopathy of Prematurity, Third Edition 47
Time Course of Retinopathy of Prematurity Regression and Reactivation After Treatment with Ranibizumab or Laser in the RAINBOW Trial 46
Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study 42
P Score: A Reference Image-Based Clinical Grading Scale for Vascular Change in Retinopathy of Prematurity 41
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): five-year outcomes of a randomised trial 40
Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial 39
Artificial Intelligence for Retinopathy of Prematurity: Validation of a Vascular Severity Scale against International Expert Diagnosis 36
Ranibizumab population pharmacokinetics and free vegf pharmacodynamics in preterm infants with retinopathy of prematurity in the rainbow trial 32
Totale 4.102
Categoria #
all - tutte 16.880
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.880


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021144 0 0 0 0 0 10 25 8 32 12 51 6
2021/2022265 25 20 2 12 10 5 3 59 16 14 33 66
2022/2023706 83 123 64 87 49 80 51 50 85 9 17 8
2023/2024289 20 75 23 11 5 57 14 3 5 19 36 21
2024/2025695 13 18 56 23 38 28 35 26 126 63 143 126
2025/20261.049 284 73 122 224 273 73 0 0 0 0 0 0
Totale 4.102